TrialNature aging2023

TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's disease.

Melanie Shulman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.